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Abstract
Background:  Escherichia coli has been most widely used for the production of valuable
recombinant proteins. However, over-production of heterologous proteins in E. coli frequently
leads to their misfolding and aggregation yielding inclusion bodies. Previous attempts to refold the
inclusion bodies into bioactive forms usually result in poor recovery and account for the major cost
in industrial production of desired proteins from recombinant E. coli. Here, we describe the
successful use of the immobilized folding machineries for in vitro refolding with the examples of high
yield refolding of a ribonuclease A (RNase A) and cyclohexanone monooxygenase (CHMO).
Results:  We have generated refolding-facilitating media immobilized with three folding
machineries, mini-chaperone (a monomeric apical domain consisting of residues 191–345 of
GroEL) and two foldases (DsbA and human peptidyl-prolyl cis-trans isomerase) by mimicking
oxidative refolding chromatography. For efficient and simple purification and immobilization
simultaneously, folding machineries were fused with the positively-charged consecutive 10-arginine
tag at their C-terminal. The immobilized folding machineries were fully functional when assayed in
a batch mode. When the refolding-facilitating matrices were applied to the refolding of denatured
and reduced RNase A and CHMO, both of which contain many cysteine and proline residues,
RNase A and CHMO were recovered in 73% and 53% yield of soluble protein with full enzyme
activity, respectively.
Conclusion: The refolding-facilitating media presented here could be a cost-efficient platform and
should be applicable to refold a wide range of E. coli inclusion bodies in high yield with biological
function.
Background
Escherichia coli retains its dominant position as the first
choice of host for the high-throughput production of
proteins of therapeutic or commercial interest because of
rapid biomass accumulation, well-established genetic
manipulation methods and simple process scale-up
[1,2]. However, a major disadvantage derived from the
intrinsic properties of E. coli is the frequent formation of
an inclusion body, a dense aggregate of misfolded
polypeptides [3]. Refolding the inclusion bodies into the
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native conformation might be straightforward if an effi-
cient refolding scheme is established. There are a variety
of conventional methodologies for refolding recom-
binant proteins from inclusion bodies, which contains
simple dilution, dialysis and chromatographic refolding
methods. Dilution is the simplest and most widely used
technique and involves refolding initiation by reducing
the denaturant concentration. However, the target prod-
uct in dilution refolding can be obtained only very low
yield because of protein aggregation at high protein con-
centration. Column-based refolding is the most likely to
renaturate the protein aggregates at high concentration
and to reduce the cost for reagents and buffers in large-
scale protein refolding [4]. Although these conventional
methods are commonly used for protein refolding and
quite progress has been made, disulfide bond formation
and peptidyl-prolyl cis-trans  isomerization have often
frustrated the successful refolding of insoluble recom-
binant proteins containing cysteine and proline in mul-
tiple numbers [5,6]. Generation of correct disulfide
bonds and peptidyl-prolyl cis-trans  configuration are
required processes for formation and stabilization of the
native protein conformation. Furthermore, the kinetics
and thermodynamics of disulfide bond formation and
peptidyl-prolyl cis-trans isomerization can dominate the
rate and pathway of protein folding and in turn deter-
mine the refolding efficiency [7,8].
At least two classes of cellular factors are currently known
to assist in vivo or in vitro protein folding. The first class
includes a number of proteins collectively known as
"molecular chaperones" such as GroEL-GroES and DnaK/
DnaJ/GrpE in E. coli. Molecular chaperones are believed to
prevent undesirable folding pathways such as premature
folding, aggregation and misfolding and thereby facilitate
formation of biologically active protein structures [9]. The
second class contains foldases that catalyze protein fold-
ing by stimulating rate-limiting reactions such as the for-
mation and interchange of disulfide bonds and
isomerization of peptidyl-prolyl bonds [9]. The respective
enzymes are protein disulfide bond isomerase and pepti-
dyl-prolyl cis-trans isomerase (PPIase). Recently, the appli-
cation of these proteins in helping in vitro protein
refolding has been studied actively [10,11]. GroEL mono-
mer is composed of three domains: an apical domain that
is responsible for binding substrate [12], an equatorial
domain that contains the ATP-binding site, and an inter-
mediate hinge domain that connects the apical and equa-
torial domains. The monomeric apical domain of GroEL
(mini-chaperone or mini-GroEL) was proved to trigger
the in vitro refolding of rhodanase and cyclophilin A with-
out GroES and ATP and had the activity of intact GroEL in
vivo [12]. The immobilized mini-chaperone and foldases
were successfully employed in column chromatography
and batchwise mode to refold indole 3-glycerol phos-
phate synthase, cyclodextrin glycosyltransferase, antibody
fragments and the scorpion toxin Cn5 in high yield with
biological activity [13-16].
Here, we report a simple method that enables one-step
purification and immobilization of folding machineries
(mini-chaperone, DsbA and human PPIase) simultane-
ously in fully functional forms using the positively-
charged consecutive 10-arginine tag at their C-terminal.
Further, the folding-catalytic matrices immobilized with
mini-chaperone and/or two foldases were recruited to
refold two denatured and reduced model proteins con-
taining multiple cysteine or proline residues for proving
their refolding-assisting efficiency. This report provides an
affordable refolding method using immobilized folding
machineries to lead the rapid provision of the protein of
interest from inclusion bodies produced in E. coli.
Results
Preparation of folding machineries
In order to obtain the recombinant folding machineries in
E. coli, the PCR product coding for mini-chaperone, DsbA
or human PPIase (hPPIase) was cloned into template vec-
tor harnessing the Arg10 tag. Mini-chaperone and DsbA
expressed in E. coli BL21(DE3) were completely soluble
and active form while approximately 50% of the total
hPPIase protein was soluble and the rest of the protein
was in the insoluble fraction (Fig. 1A). The recombinant
E. coli BL21(DE3) cells transformed with the correspond-
ing expression plasmid of folding machineries produced
mini-chaperone, DsbA or hPPIase as soluble protein in
final yield of about 0.41, 0.45 and 0.32 g/L of culture,
respectively. After simple one-step salt-gradient ion-
exchange chromatography using soluble E. coli cell
extracts, Arg10-tailed folding catalysts were purified to
more than 95% estimated from the sodium dodecyl sul-
fate polyacrylamide gel electrophoresis (SDS-PAGE) anal-
ysis (Fig. 1B, inner panel) and their predicted molecular
weight were verified by matrix assisted laser desorption-
ionization and time of flight (MALDI-TOF) mass spec-
trometry (Fig. 1B). The simply and efficiently purified
folding machineries with Arg10-tails at their C-terminal
were used for subsequent immobilization and refolding
experiments.
Construction of refolding matrices
Initially, the SP-Sepharose Fast Flow resin was used to
immobilize purified folding machineries for preparative
purposes. Due to the stretch of 10 consecutive positively
charged Arg residues of folding machineries, the purified
fusion protein was immobilized noncovalently by polyi-
onic interaction to the matrix containing polyanion as a
functional group, which yielded mini-chaperone-Sepha-
rose, DsbA-Sepharose and hPPIase-Sepharose. To meas-
ure coupling density, various amounts of purified folding
machineries were mixed with the cation exchanger. The
amount of immobilized folding machineries wasBMC Biotechnology 2009, 9:27 http://www.biomedcentral.com/1472-6750/9/27
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Production of folding machineries from recombinant E. coli Figure 1
Production of folding machineries from recombinant E. coli. (A) SDS-PAGE analysis of the expression of Arg10-tagged 
folding machineries in E. coli cultures incubated at 37°C for 6 hr and induced by 0.5 mM IPTG. I, insoluble fraction; M, molecular 
mass marker; S, soluble fraction; T, total cell lysates. (B) MALDI-TOF analysis of folding machineries purified by a simple ion-
exchange chromatography. Mass spectra of purified folding machinery proteins: 3 (mini-chaperone and hPPIase) or 1 (DsbA) 
ionization states that match the molecular mass prediction of each folding machinery protein. The expressed and purified fold-
ing machinery proteins are indicated by arrows.BMC Biotechnology 2009, 9:27 http://www.biomedcentral.com/1472-6750/9/27
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increased as the loading amount of folding machineries
into the cation exchanger was increased (Fig. 2). The max-
imum amount of the folding machineries coupled to the
resin as follows: mini-chaperone, 12.2 mg/mL gel; DsbA,
10.8 mg/mL gel; hPPIase, 11.7 mg/mL gel. Binary (mini-
chaperone/DsbA-, mini-chaperone/hPPIase- and DsbA/
hPPIase-Sepharose) and ternary (mini-chaperone/DsbA/
hPPIase-Sepharose) refolding matrices were prepared by
thoroughly mixing in equal molar ratios of the single
refolding gel (mini-chaperone-Sepharose, DsbA-Sepha-
rose and hPPIase-Sepharose).
Functional analyses of immobilized folding machineries
Immobilized mini-chaperone was fully functional in
refolding a typical substrate, denatured carbonic anhydrase
(data not shown). Immobilized foldases (DsbA and hPPI-
ase) were assayed on the basis of their enzymatic activities.
Immobilized DsbA was tested for its ability to catalyze pro-
tein disulfide bond formation. An RNase A with scrambled
disulfide bridges was incubated with DsbA-Sepharose in
the presence of excess GSH over GSSG. The recovery of
RNase A activity was significantly higher in the presence of
DsbA-Sepharose than the case with SP Sepharose without
DsbA and the immobilized DsbA effect was concentration-
dependent (Fig. 3A). Immobilized hPPIase assay was car-
ried out based on the observation that chymotrypsin
cleaved the C-terminal amide bond only in the trans X-Pro
conformer of the chromogenic substrate, X-Pro-Phe-p-
nitroanilide (X is any amino acid) [17]. Immobilized hPPI-
ase can catalyze the cis-trans interconversion of the Ala-Pro
bond in the substrate N-Suc-AAPF-p-nitroanilide compared
to the level of spontaneous isomerization in the absence of
immobilized hPPIase (Fig. 3B). The burst phase due to the
cleavage of the excess trans isomer is completed during the
mixing time and the remaining absorbance change is due
to the cis-trans isomerization catalyzed by the immobilized
hPPIase (Fig. 3B).
Batchwise refolding of denatured and reduced proteins
The immobilized folding machineries were found to facil-
itate the refolding of denatured and reduced RNase A with
Coupling density of folding machineries to a cation exchanger Figure 2
Coupling density of folding machineries to a cation 
exchanger. Various amounts of purified folding machineries 
were mixed with the cation exchanger, SP Sepharose Fast 
Flow. The folding machineries-bound SP Sepharose was 
mixed with 2 bead volume of 50 mM sodium phosphate 
buffer, pH 8.4 containing 1 M NaCl. After gentle mixing for 
30 min at 25°C, the bead was removed by centrifugation and 
the supernatant was then used to the determination of pro-
tein concentration.
Functional analysis of immobilized folding machineries, DsbA  and hPPIase Figure 3
Functional analysis of immobilized folding machiner-
ies, DsbA and hPPIase. DsbA (A) and hPPIase (B) assay 
were based on their enzymatic properties to catalyze protein 
disulfide bond formation and cis-trans interconversion of the 
peptidyl-prolyl bond, respectively. RNase A with scrambled 
disulfide bonds and N-Suc-AAPF-p-nitroanilide were used for 
determination of activities of immobilized DsbA and hPPIase 
as substrate as described in Methods section.BMC Biotechnology 2009, 9:27 http://www.biomedcentral.com/1472-6750/9/27
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high efficiency (Table 1). The refolding efficiency is the
ratio of the soluble fraction to the total amount of dena-
tured and reduced protein used for refolding and the func-
tional recovery is estimated from the specific activity of
the recovered soluble protein relative to that of native
enzyme. The hPPIase-Sepharose used for the refolding of
RNase A generated a 67% refolding yield, while 17.2%
was observed using SP Sepharose Fast Flow alone. The
mini-chaperone-Sepharose and DsbA-Sepharose gave
refolding yields of about 55% and 58%, respectively
(Table 1). The binary refolding matrices showed similar
refolding yields to single refolding matrices. The binary
refolding matrix of mini-chaperone/DsbA-Sepharose gave
a high yield of protein folding, which was corresponding
to 68% efficiency. The ternary matrix (mini-chaperone/
DsbA/hPPIase-Sepharose) gave the highest yield of 73%
among all kinds of the refolding matrices. The RNase A
prior to the denaturation and reduction initially had 76%
of the activity of the purest protein under our assay condi-
tion. Further, the maximum activity recovery was 31%
more than that initially present. Thus, the refolding matri-
ces had reconditioned the RNase A by converting inactive
protein into active. Reconditioning activity has been pro-
posed as a general property of refolding systems using
immobilized foldases [13,16]. We have applied the same
procedure to another protein, cyclohexanone monooxy-
genase (CHMO) expressed as inclusion bodies from
recombinant E. coli BL21(DE3). More than 99% activity
yield was obtained on batchwise refolding of CHMO with
refolding matrices. The refolding efficiency of CHMO
inclusion body using the folding machineries displayed
on the cation exchanger was also shown in Table 1. The SP
Sepharose Fast Flow by itself produced less than 2.1% of
refolding yield, which was all aggregated. Among single
refolding gels, mini-chaperone-Sepharose showed the
highest refolding yield of 31%. Binary refolding matrices
exhibited better results than single refolding matrices. The
mini-chaperone/hPPIase-Sepharose generated the best
refolding yield of 46% in the group of binary refolding
matrix. The ternary matrix (mini-chaperone/DsbA/hPPI-
ase-Sepharose) gave the highest yield of 53% among all
types of the refolding matrices. Similar to RNase A, the
native CHMO used for comparison of activity recovered
from refolding matrices initially had 80% of the activity of
the purest protein under our assay condition. Moreover,
the highest recovery of CHMO activity was 25% more
than that initially present, suggesting the reconditioning
of CHMO activity by refolding matrices immobilized
folding machineries. No leakage of folding machineries
from the cation exchanger was observed during the refold-
ing process, which was confirmed by SDS-PAGE (data not
shown).
CD analysis of refolded proteins
The CD spectrum of refolded RNase A showing a mini-
mum at 210 nm in the far ultraviolet (UV) region indi-
cated that the refolded RNase A has a native-like
secondary structure after comparison with the native
RNase A (Fig. 4A). The denatured RNase A in 6 M Gdn-
HCl, which has an unfolded conformation, exhibited a
distinctly different CD spectrum. In the far UV-CD region,
the spectrum of refolded CHMO showed two minima at
205 nm and 215 nm and it was observed to overlay very
closely with that of native CHMO (Fig. 4B), suggesting
that the refolded CHMO has a very comparable secondary
structure to the soluble and native CHMO. This CD spec-
trum of the refolded CHMO is similar to that of native
CHMO of another group [18].
Discussion
Protein aggregation during production and refolding
from the inclusion body of many industrial and pharma-
ceutical proteins in E. coli has been a major technical and
economical bottleneck that has spurred basic research as
Table 1: Batchwise refolding of denatured and reduced RNase A and CHMO.
RNase A CHMO
Refolding condition Refolding yield* (%) Activity yield† (%) Refolding yield (%) Activity yield (%)
SP Sepharose Fast Flow alone (control) 17.2 ± 1.4 33 ± 3 2.1 ± 0.7 17 ± 2
Single refolding matrix Mini-chaperone 55.0 ± 2.1 98 ± 5 31.0 ± 1.6 107 ± 6
DsbA 57.6 ± 2.4 121 ± 12 8.5 ± 1.3 99 ± 3
hPPIase 67.0 ± 3.3 115 ± 9 11.0 ± 2.2 103 ± 8
Binary refolding matrix Mini-chaperone + DsbA 68.0 ± 1.8 107 ± 5 27.1 ± 2.4 109 ± 11
Mini-chaperone + hPPIase 56.7 ± 2.7 118 ± 7 46.2 ± 1.8 123 ± 8
DsbA + hPPIase 58.4 ± 2.6 126 ± 2 13.8 ± 1.5 111 ± 10
Ternary refolding matrix Mini-chaperone + DsbA + 
hPPIase
73.0 ± 1.5 131 ± 3 53.0 ± 2.7 125 ± 4
Data were collected from three independent refolding experiments with identical protein concentration.
* Refolding yield: the ratio of the soluble protein to the total amount of denatured and reduced protein used for refolding.
†Activity yield: the specific activity of the recovered soluble protein relative to that of native RNase A or CHMO showing 76% or 80% of the 
specific activity of the purest protein obtained from Sigma CompanyBMC Biotechnology 2009, 9:27 http://www.biomedcentral.com/1472-6750/9/27
Page 6 of 10
(page number not for citation purposes)
well as process development [19]. Among various
approaches to overcome protein aggregation in refolding
processes, refolding chromatography systems mimicking
in vivo folding systems are introduced as an efficient and
simple way to renature proteins in high yields [13,16].
However, refolding reaction stoichiometry requires a con-
siderable amount of folding machineries [20]. Therefore,
a cost-efficient purification and immobilization of folding
machineries is a critical step in order to apply this refold-
ing methodology to a large bioprocess scale. Previously,
protein disulfide isomerase (PDI) has been immobilized
only in low yield and is not active [21]. It is mainly due to
very reactive thiol groups in PDI. Altamirano et al. [16]
reported the first successful immobilization of DsbA as a
fully functional form. They could immobilize the DsbA
on agarose by transiently blocking the active site by cyan-
ylation. However, this technique is still challenging to
repeat and cost-inefficient. In this study, we report a sim-
ple method that enables simultaneous purification and
immobilization of folding machineries in fully functional
forms. Among a variety of immobilization methods,
adsorption is simpler and less expensive, with minimal
chemical requirements and less likelihood of enzyme
denaturation. However, the weak nature of the binding
forces can cause leakage of the enzyme with changes in
pH, ionic strength and/or temperature. In order to prevent
leakage of proteins from the solid support and to exploit
the simple adsorption method, the folding catalysts were
charged by attaching 10-arginine amino acids. Specifi-
cally, the charged consecutive Arg10-stretch was geneti-
cally fused to the C-terminal of the mini-chaperone, DsbA
and hPPIase to generate the charge-added folding cata-
lysts. The generated folding catalysts were analyzed for
their purification and immobilization characteristics. A
single ion-exchange chromatography was performed for
the one-step purification of the soluble folding machiner-
ies. Most intracellular proteins of E. coli have their isoelec-
tric points (pI) at weak acidic pH in analysis of the wild
type E. coli proteome [22]. Ninety-seven percent of intrac-
ellular proteins have pI values below pH 8.4, the same pH
value of loading buffer, with only 3% at basic pH. It indi-
cates that more than 97% E. coli proteins are negatively
charged at pH 8.4 and cannot be bound on a cation
exchanger. The calculated pI values of mini-chaperone,
DsbA and hPPIase with Arg10 stretch was 9.43, 9.41 and
10.23, respectively, implying that the folding machineries
have positive charges in 50 mM sodium phosphate buffer,
pH 8.4. Therefore, they were easily purified with high
purity form the negatively charged intracellular E. coli pro-
teins using a single step of cation exchange chromatogra-
phy. Further, Arg10-tail provided a simple and firm
strategy for the immobilization of folding machineries.
Efficient immobilization of folding machineries on a cat-
ion exchanger was achieved using an adsorption based on
electrostatic interaction. The maximum amounts of the
immobilized folding machinery reached 10.8 – 12.2 mg/
ml and were higher than those of other groups reported
previously [16]. The immobilized mini-chaperone and
foldases were fully functional when assayed in a batch
mode. The targeted benefit of immobilization of folding
CD spectra of RNase A and CHMO refolded with the ter- nary refolding matrix (mini-chaperone, DsbA and hPPIase) Figure 4
CD spectra of RNase A and CHMO refolded with the 
ternary refolding matrix (mini-chaperone, DsbA and 
hPPIase). The CD spectra refolded RNase A (A) and 
CHMO (B) were compared with those of native and dena-
tured and reduced RNase A and CHMO, respectively. The 
CD spectra were obtained using a JASCO J-715 in a quartz 
cuvette with 1 mm path length. RNase A and CHMO 
refolded by the ternary refolding gel was dissolved in 25 mM 
sodium phosphate buffer, pH 7.0 at 0.05 mg/ml.BMC Biotechnology 2009, 9:27 http://www.biomedcentral.com/1472-6750/9/27
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catalysts is easy separation of the refolded protein from
the other components and the immobilization procedure
increases the efficiency of the folding machineries, since
higher concentrations of the active folding machineries
can be achieved in the gel than in solution.
Recombinant proteins of industrial and pharmaceutical
interest may have disulfide bonds and many are difficult
to refold. After successful purification and immobiliza-
tion of folding catalysts, we applied immobilized mini-
chaperone and foldases to refold the cysteine- and pro-
line-rich proteins. The first model protein is bovine pan-
creatic RNase A consisting of 124 amino acid residues
and contains 8 cysteine residues involving in formation
of 4 intramolecular disulfide bonds and 5 proline resi-
dues. The remarkable renaturation was achieved when
the unfolded RNase A was treated with the individual
immobilized folding machinery, suggesting that the
immobilization of folding machineries on a cation
exchanger through 10-arginine fusion did not inhibit
their chaperone activity. This result contrasts with the
spontaneous renaturation by the SP Sepharose Fast Flow
in refolding buffer (Table 1). In addition, combination
of the appropriate amounts of each gel makes it easier to
find the optimal refolding conditions of the other target
proteins because each gel has a similar refolding effi-
ciency. The complete refolding matrices (mini-chaper-
one/DsbA and mini-chaperone/DsbA/hPPIase) proved
to be highly efficient (68% and 73%, respectively) in
restoring the native structure and biological properties of
the RNase A. The synergistic effect of DsbA with PPIase
and of GroEL with PDI has been observed in vivo and in
vitro, indicating that they play cooperative roles in pro-
tein refolding [23,24]. The refolded RNase A recovers a
native-like secondary structure based on its similar CD
spectrum to that of native RNase A. The second model
protein, CHMO derived from Acinetobacter sp. is one of
the oxidative enzymes of special interest as a biocatalyst
in the NADPH-dependent oxidation of cyclohexanone
to  ε-caprolactone  via  a Baeyer-Villiger mechanism. It
comprises 543 amino acids and contains 5 cysteines and
22 prolines. When the disulfide bonds prediction was
performed using DiANNA, which is recent state-of-the-
art web-based software determining the cysteine oxida-
tion state and disulfide connectivity of a protein [25], the
result showed that 4 of 5 cysteine residues might be
involved in the formation of two intramolecular
disulfide bonds (Cys330-Cyss475 and Cys376-Cys520). The
CHMO deposited as inclusion bodies in recombinant E.
coli could be refolded with 53% yield using the ternary
refolding matrices (mini-chaperone/DsbA/hPPIase-
Sepharose) while the negligible refolding yield was
achieved using the SP Sepharose resin alone. The other
refolding matrices also assisted the batchwise mode of
CHMO refolding (Table 1).
Conclusion
This work demonstrates that a commonly used and rela-
tively inexpensive ion-exchange matrix can be used for
immobilization of folding catalysts. Refolding was not
inhibited by protein-matrix interactions thus preventing
the need for tagged protein in an affinity based method.
Refolded protein was directly obtained from the refolding
matrix in a highly concentrated form and free from incor-
rectly or incompletely refolded protein. This indicates that
the proposed method can contribute significantly to bio-
process intensification as it integrates the reducing-agent
removal, refolding, concentration and purification unit
operations used in dilution refolding into an easily auto-
mated process. Therefore, the method is an interesting
alternative for large-scale or preparative oxidative refold-
ing of complex and highly disulfide-bonded proteins.
Results reported here showed an effective refolding tech-
nique for proline- or cysteine-rich proteins obtained from
E. coli inclusion bodies, which might be potential in the
biotechnology industry.
Methods
Materials
Oligonucleotides were synthesized by Bioneer (Daejeon,
Korea). All restriction enzymes were from New England
Biolabs. The vector pET-29b(+) was obtained from Nova-
gen.E. coli DH5α and BL21(DE3) cells were used for
maintenance of plasmids and for the production of
recombinant proteins, respectively. Plasmid, gel extrac-
tion and PCR purification kits were purchased from Qia-
Table 2: Oligonucleotide sequences used in this study.
Name Sequence of oligonucleotide
R10A 5'-GATCCCGTCGCCGTCGCCGTCGCCGTCGCCGTCGCTACTAAC-3'
R10B 5'-TCGAGTTAGTAGCGACGGCGACGGCGACGGCGACGGCGACGG-3'
DsbA5 5'-TATCAACATATGAAAAAGATTTGGCTGGC-3'
DsbA3 5'-GCATTGGGATCCTTTTTTCTCGGACAGATATTTC-3'
HPPI5 5'-TATCAACATATGGTCAACCCCACCGTG-3'
HPPI3 5'-GCATTGGGATCCTTCGAGTTGTCCACAGTCAG-3'
Mini5 5'-TATCAACATATGGAAGGTATGCAGTTCGACC-3'
Mini3 5'-GCATTGGGATCCACGGCCCTGGATTGCAGC-3'BMC Biotechnology 2009, 9:27 http://www.biomedcentral.com/1472-6750/9/27
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gen. RNase A type XII-A from bovine pancreas, RNase A
with scrambled disulfide bonds, cyclohexanone monoox-
ygenase (CHMO) of Acinetobacter sp. expressed in recom-
binant E. coli, cytidine 2', 3'-cyclic monophosphate (2', 3'-
cCMP), N-Succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (N-
Suc-AAPF-p-nitroanilide) and α-chymotrypsin (α-CT)
were purchased from Sigma-Aldrich. All other chemicals
unless otherwise stated were of reagent grade.
Construction of template plasmid with Arg10-tag
Standard cloning procedures were performed according to
Sambrook and Russell [26]. In order to construct the tem-
plate plasmid with an Arg10-tail, mixture of complemen-
tary oligonucleotides (R10A and R10B) were heated to
90°C and cooled slowly to room temperature. The
annealed double-stranded DNA was subjected to kination
as follows: total 30 μl of reaction solution containing 20
μl of 100 pmoles/μl DNA, 3 μl of 10 × polynucleotide
kinase buffer, 3 μl of 10 mM ATP, 1 μl of T4 polynucle-
otide kinase and 3 μl of distilled deionized water was
incubated at 37°C for 1 hr and heat-inactivated at 75°C
for 20 min. Phosphorylated DNA was inserted to the pET-
29b(+) fragment which had been digested by BamHI and
XhoI followed by dephosphorylation with calf intestinal
phosphatase at 37°C for 1 hr. The resulting template plas-
mid that contains the 10-arginine residues was named by
pETR10. The oligonucleotide primers used in this study
are shown in Table 2.
Construction of expression plasmids
To construct expression vectors for folding machineries
with C-terminal Arg10-tag, genes for mini-chaperone,
DsbA and hPPIase were amplified by PCR from the chro-
mosomal DNA of E. coli K-12 or from the cDNA of hPPI-
ase gene as template. The primer sets used for
amplification of folding machineries are as follows: Mini5
and Mini3 for mini-chaperone; DsbA5 and DsbA3 for
DsbA; HPPI5 and HPPI3 for hPPIase (Table 2). The
amplified DNA fragments were digested by NdeI and
BamHI and cloned into the template vector pETR10
digested by the same restriction enzymes. The resulting 3
expression vectors are named as pMiniELR10, pDsbAR10,
and pHPPIR10, respectively.
Expression and purification of folding machineries
In order to prepare the folding machineries, E. coli
BL21(DE3) cells harboring expression vectors for folding
machineries were cultured in 200 ml Luria-Bertani (LB)
medium (0.5% yeast extract, 1% tryptone and 1% NaCl)
supplemented with 50 μg/ml kanamycin at 30°C and
induced with 0.5 mM isopropyl-β-thiogalactopyranoside
(IPTG) at an OD600 of 0.5. After 6 hr induction, cells were
harvested by centrifugation at 8000 × g for 30 min at 4°C.
The harvested cells were resuspended in 20 ml of 50 mM
sodium phosphate buffer, pH 8.4 and then disrupted by
French Press (Thermo Spectronic) at 20,000 psi in an ice
bath. After removing cell debris by centrifugation, the
resulting supernatant was directly loaded onto an ion-
exchange column for purification. An automated chroma-
tography system, ÄKTA prime (GE Healthcare Life Sci-
ences) was used to monitor the protein elution peak. The
ion-exchange column, HiTrap Sepharose Fast Flow (GE
Healthcare Life Sciences) loaded with E. coli cell extracts
was washed with 10 column volumes of 50 mM sodium
phosphate buffer, pH 8.4 at a flow rate of 1.0 ml/min. The
unbound proteins were washed out at this step. Continu-
ous linear gradient from 0 to 1 M NaCl was applied to sep-
arate the proteins bound to the cation exchanger. The
absorbance at 280 nm and the conductivity in the eluent
were observed. The final eluted fractions were collected
and subjected to further analyses.
Protein quantification and detection
Protein concentration was determined by the Bradford
method using the protein assay kit (Bio-Rad) according to
the manufacturer's instructions. Protein samples were
analyzed by SDS-PAGE using 12% gels and detected by
staining the gels with Coomassie brilliant blue R-250. The
dried SDS-PAGE gels were imaged and digitized with a
high resolution scanner (Scanjet ADF, Hewlett Packard).
The quantification of bands intensity and purity was car-
ried out using the densitometry software (TotalLab 1.01,
Nonlinear Dynamics Ltd.).
MALDI-TOF analysis of purified folding machineries
Mass spectra of purified folding catalyst proteins were col-
lected by MALDI-TOF (Voyager-DE Biospectrometry
Workstation). The purified folding machinery proteins
were mixed with 3, 5-dimethyl-4-hydroxycinnamic acid
as a matrix, dropped on a sample plate and air dried until
crystallization occurred. Then the sample plate was
loaded and analyzed the molecular weight at the proper
conditions.
Preparation of denatured and reduced model proteins
For the preparation of denatured and reduced CHMO,E.
coli BL21(DE3) cells containing pMM4 for CHMO expres-
sion [27] were grown at 37°C in LB supplemented with
100 μg/ml ampicillin. Expression was induced by adding
IPTG to a final concentration of 1 mM when the culture
was grown to OD600 of about 0.5. After induction for 6 hr,
cells were harvested by centrifugation at 8000 × g for 30
min and resuspended in lysis buffer (10 mM Tris-HCl, 1
mM EDTA and 100 mM monobasic sodium phosphate,
pH 8.0). After the cells were disrupted by being passed
two times through the French Press at 20,000 psi, cell
lysates were centrifuged at 12000 × g for 30 min to remove
soluble proteins of E. coli and the precipitates were resus-
pended in washing buffer (2% Triton X-100, 20 mM
EDTA and 100 mM monobasic sodium phosphate, pH
8.0). This step was repeated three times to wash out resid-
ual soluble proteins. The washed insoluble pellet wasBMC Biotechnology 2009, 9:27 http://www.biomedcentral.com/1472-6750/9/27
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defined as CHMO inclusion body. The CHMO inclusion
body and RNase A type XII-A (Sigma-Aldrich) were dena-
tured and reduced in a solution containing 6 M guanidine
hydrochloride (GdnHCl), 0.14 M DTT and 2 mM EDTA in
50 mM MOPS buffer, pH 8.0. Each solution was incu-
bated for at least 12 hr at 25°C. The denaturation buffer
was prepared just prior to use. The activities of denatured
and reduced CHMO and RNase A were measured to con-
firm their fully denatured and reduced states.
Enzymatic activity assay
For the enzyme activity assay of RNase A, cleavage of
phosphodiester bonds was monitored. RNase A (5 – 100
μl of a stock solution in 100 mM Tris-acetate buffer, pH
8.0) was added to solutions containing 2', 3'-cCMP, Gdn-
HCl, EDTA and DTT in 50 mM Tris-acetate buffer, pH 8.0
to give a final volume of 400 μl with 4.5 mM 2', 3'- cCMP,
0.6 M GdnHCl, 0.2 mM EDTA and 14 mM DTT. The
changes in absorbance were followed in thermostatic
quartz cuvette (1 cm length) at 296 nm using an Ultrospec
4000 spectrophotometer (GE Healthcare Life Sciences).
CHMO activity was determined from the rate of NADPH
consumption upon the addition of cyclohexanone to the
reaction mixture [28]. The assay mixture contains, in a
final volume of 400 μl, 40 μl of 4.0 mM NADPH, 20 μl of
crude enzyme solution with 0.01 – 0.2 units of activity
and 330 μl of 0.1 M Glycine/NaOH buffer, pH 9.0. An
endogenous rate of NADPH consumption was measured
by pre-incubation at 30°C in the thermostatic cell holder
of the spectrophotometer for 2 min prior to the addition
of 25 mM cyclohexanone to the assay mixture. After pre-
incubation, 10 μl of cyclohexanone is added and the
decrease in absorbance at 340 nm is monitored. CHMO
activity was calculated as the difference between the
endogenous rate of cofactor consumption and the stimu-
lated rate of NADPH oxidation. Disulfide isomerization
activity of immobilized DsbA was measured as described
by the previous report with some modifications [29].
Inactive RNase A with scrambled disulfide bonds was
used for its activity recovery catalyzed by the disulfide
shuffling activity of DsbA. Briefly, RNase A with scram-
bled disulfide bonds (final concentration, 0.2 mg/ml) was
incubated in 3.6 mM GSH, 0.9 mM GSSG, 1 mM EDTA
and 100 mM Tris-acetate buffer pH 8.0 in the presence or
absence of immobilized DsbA. This reaction solution was
mixed with 360 μl of 2', 3'-cCMP (0.1 mg/ml) in 0.1 M
MOPS buffer, pH 7.0 and incubated at 25°C for 5 min.
After gentle mixing, the cuvette was placed in the spectro-
photometer for 20 min to allow thermal equilibration of
the solution to 25°C. Hydrolysis of 2', 3'-cCMP was meas-
ured by the increase in absorption at 296 nm. The hPPIase
activity was determined by a coupled assay with α-CT
using the short synthetic peptide substrate, N-Suc-AAPF-p-
nitroanilide in 88% trans, 12% cis configuration [17]. The
hPPIase activity was measured as the cis-trans isomeriza-
tion of the alanine-proline peptide bond in the peptide.
The assay relies on the inability of α-CT to hydrolyze N-
Suc-AA-cis-PF-p-nitroanilide. The substrate will be rapidly
hydrolyzed to N-Suc-AA-trans-PF-p-nitroanilide and
released  p-nitroanilide is quantified spectrophotometri-
cally at 390 nm. The assay buffer (940 μl of 20 mM
sodium phosphate buffer pH 8.0), 50 μl of gels displayed
with the hPPIase protein (1.2 nmol) and the peptide sub-
strate (20 μl of 4 mM stock solution dissolved in DMSO;
final concentration 70 μM) were pre-equilibrated in the
spectrophotometer for 10 min. Immediately before the
assay was started, α-CT (30 μl of 2.24 mM stock solution
in 1.0 mM HCl; final concentration 75 μM) solution was
added. The final volume in a masked, semi-micro 1-cm
path length cell was 1.0 ml. After a delay from the onset of
mixing, the absorbance of p-nitroanilide was followed at
390 nm until the reaction was complete. Absorbance
readings were collected on the spectrophotometer inter-
faced to a computer, by use of commercial data acquisi-
tion software (SWIFT, GE Healthcare Life Sciences).
Construction of refolding matrices
A cation exchanger (SP Sepharose Fast Flow) was pre-
equilibrated with 50 mM sodium phosphate buffer, pH
8.4. Each folding catalyst (mini-chaperone, DsbA and
hPPIase) in the same buffer was separately added to the
pre-equilibrated cation exchanger and mixed for at least 2
hr with gentle shaking. The resulting refolding gels immo-
bilized with each protein (mini-chaperone-Sepharose,
DsbA-Sepharose and hPPIase-Sepharose) were thor-
oughly mixed in equal molar ratios of the proteins to
make binary and ternary refolding gels. The unbound pro-
teins were subsequently removed by washing with 50 mM
sodium phosphate buffer, pH 8.4. In order to determine
the binding capacity of folding machineries into the cat-
ion exchanger, each refolding gel immobilized with fold-
ing machineries was mixed with 2 bead volumes of 50
mM sodium phosphate buffer, pH 8.4 containing 1 M
NaCl. After gentle mixing for 30 min at 25°C, the solid
bead was eliminated by centrifugation. The supernatant
was then subjected to the determination of protein. This
procedure was repeated twice, which yield virtually the
same protein concentration bound to SP Sepharose Fast
Flow within the experimental error range of ± 5%.
Refolding of RNase A and CHMO
The refolding of denatured and reduced CHMO and
RNase A was performed according to the method of
Altamirano et al. [16]. Refolding was initiated by equili-
bration of the refolding gels with refolding buffer contain-
ing 50 mM MOPS buffer, pH 8.0, 1.0 mM GSH, 0.2 mM
GSSG and 14 mM DTT. In all cases, the denatured and
reduced model proteins (100 μg in 40 μl) were very slowly
mixed and diluted 100-fold with a resuspension of the
refolding matrix and kept at 25°C under gentle mixing.
After incubation for 10 min, the gel suspension was then
centrifuged at 6000 × g for 10 min to separate the super-BMC Biotechnology 2009, 9:27 http://www.biomedcentral.com/1472-6750/9/27
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natant. The supernatants (soluble proteins) were eventu-
ally concentrated and desalted by Vivaspin concentrators
(vivaspin 500; 5,000 MWCO PES, VivaScience) according
to the manufacturer's instruction. The concentration and
enzyme activity of refolded protein in the supernatant
were determined and the amount of soluble protein was
subtracted from the total proteins subjected to the initial
refolding procedure to estimate the amount of aggrega-
tion. Control experiments were performed in which the
denatured and reduced model proteins were added to the
SP Sepharose Fast Flow equilibrated with refolding buffer
alone.
Circular dichroism (CD) spectroscopy
To examine the correct folding of RNase A and CHMO,
the RNase A and CHMO refolded by the ternary refolding
gel were dissolved in 25 mM sodium phosphate buffer,
pH 7.0 at 0.05 mg/ml. The far UV CD spectra of refolded
RNase A and CHMO were monitored between 3 and 6
min at from 190 to 260 nm with a JASCO J-715 spectro-
polarimeter (JASCO) using a quartz cuvette with 1 mm
path length. CD spectra of native and denatured and
reduced RNase A and CHMO were also recorded. Spectra
were corrected by subtracting the buffer baseline and were
averaged over 10 scans for far UV CD measurements.
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